Estimation of non-alcoholic steatohepatitis (NASH) disease using clinical information based on the optimal combination of intelligent algorithms for feature selection and classification

References

• Abdi H. 2010. Holm’s sequential Bonferroni procedure. Encyclopedia of Research Design. 1(8):1–8.
   Google Scholar
• Alkhouri N. 2020. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development. Expert Opin Investig Drugs. 29(2):115–116.
   PubMed Web of Science ®Google Scholar
• Aravind A, Bahirvani AG, Quiambao R, Gonzalo T. 2020. Machine learning technology for evaluation of liver fibrosis, inflammation activity and steatosis (LIVERFAStTM). JILSA. 12(2):31–49.
   Google Scholar
• Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. 2005. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 42(1):44–52.
   PubMed Web of Science ®Google Scholar
• Canbay A, Kälsch J, Neumann U, Rau M, Hohenester S, Baba HA, Rust C, Geier A, Heider D, Sowa JP. 2019. Non-invasive assessment of NAFLD as systemic disease—a machine learning perspective. PLoS One. 14(3):e0214436.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 67(1):328–357.
   PubMed Web of Science ®Google Scholar
• Destrempes F, Gesnik M, Chayer B, Roy-Cardinal MH, Olivié D, Giard JM, Sebastiani G, Nguyen BN, Cloutier G, Tang A. 2022. Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease. PLoS One. 17(1):e0262291.
   PubMed Web of Science ®Google Scholar
• Ding C, Peng H. 2005. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol. 3(2):185–205.
   PubMedGoogle Scholar
• Duan Z, Song P, Yang C, Deng L, Jiang Y, Deng F, Jiang X, Chen Y, Yang G, Ma Y, et al. 2022. The impact of hyperglycaemic crisis episodes on long-term outcomes for inpatients presenting with acute organ injury: a prospective, multicentre follow-up study. Front Endocrinol. 13:1–11.
   Web of Science ®Google Scholar
• Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, et al. 2017. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis. Hepatology. 65(5):1557–1565.,
   PubMed Web of Science ®Google Scholar
• Emu M, Kamal FB, Choudhury S, de Oliveira TEA. 2020. Assisting the non-invasive diagnosis of liver fibrosis stages using machine learning methods. In 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC); p. 5382–5387. IEEE.
   Google Scholar
• Fan R, Wang J, Du J. 2018. Association between body mass index and fatty liver risk: a dose-response analysis. Sci Rep. 8(1):1–7.
   PubMedGoogle Scholar
• Feng J, Xu H, Mannor S, Yan S. 2014. Robust logistic regression and classification. Adv Neural Information Processing Systems. 27:253–262.
   Google Scholar
• Fialoke S, Malarstig A, Miller MR, Dumitriu A. 2018. Application of machine learning methods to predict non-alcoholic steatohepatitis (NASH) in non-alcoholic fatty liver (NAFL) patients. In AMIA Annual Symposium Proceedings; Vol. 2018, p. 430. American Medical Informatics Association.
   Google Scholar
• Foody GM. 2004. Supervised image classification by MLP and RBF neural networks with and without an exhaustively defined set of classes. Int J Remote Sens. 25(15):3091–3104.
   Web of Science ®Google Scholar
• Forlano R, Mullish BH, Giannakeas N, Maurice JB, Angkathunyakul N, Lloyd J, Tzallas AT, Tsipouras M, Yee M, Thursz MR, et al. 2020. High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 18(9):2081–2090.e9.
   PubMed Web of Science ®Google Scholar
• García-Carretero R, Holgado-Cuadrado R, Barquero-Pérez Ó. 2021. Assessment of classification models and relevant features on nonalcoholic steatohepatitis using random forest. Entropy. 23(6):763.
   PubMed Web of Science ®Google Scholar
• Ghandian S, Thapa R, Garikipati A, Barnes G, Green‐Saxena A, Calvert J, Mao Q, Das R. 2022. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis. JGH Open. 6(3):196–204.
   PubMed Web of Science ®Google Scholar
• Graffy PM, Sandfort V, Summers RM, Pickhardt PJ. 2019. Automated liver fat quantification at nonenhanced abdominal CT for population-based steatosis assessment. Radiology. 293(2):334–342.
   PubMed Web of Science ®Google Scholar
• Hectors SJ, Kennedy P, Huang KH, Stocker D, Carbonell G, Greenspan H, Friedman S, Taouli B. 2021. Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid–enhanced MRI. Eur Radiol. 31(6):3805–3814.
   PubMed Web of Science ®Google Scholar
• Heinemann F, Birk G, Stierstorfer B. 2019. Deep learning enables pathologist-like scoring of NASH models. Sci Rep. 9(1):1–10.
   PubMedGoogle Scholar
• Jaccard P. 1901. Distribution de la flore alpine dans le bassin des Dranses et dans quelques régions voisines. Bull Soc Vaudoise Sci Nat. 37:241–272.
   Google Scholar
• Jun BG, Cheon GJ. 2019. The utility of ezetimibe therapy in nonalcoholic fatty liver disease. Korean J Intern Med. 34(2):284–285.
   PubMed Web of Science ®Google Scholar
• Karim MR, Beyan O, Zappa A, Costa IG, Rebholz-Schuhmann D, Cochez M, Decker S. 2021. Jan Deep learning-based clustering approaches for bioinformatics. Brief Bioinform. 22(1):393–415.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu Y-C, Torbenson MS, Unalp-Arida A, et al. 2005. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41(6):1313–1321.
   PubMed Web of Science ®Google Scholar
• Konishi K, Miyake T, Furukawa S, Senba H, Kanzaki S, Nakaguchi H, Yukimoto A, Nakamura Y, Watanabe T, Koizumi Y, et al. 2020. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein (a) as a cardiovascular risk factor. Atherosclerosis. 299:32–37.
   PubMed Web of Science ®Google Scholar
• Ma H, Xu CF, Shen Z, Yu CH, Li YM. 2018. Application of machine learning techniques for clinical predictive modeling: a cross-sectional study on nonalcoholic fatty liver disease in China. Biomed Res Int. 2018:1–9.
   Web of Science ®Google Scholar
• Mahabub A. 2019. A robust voting approach for diabetes prediction using traditional machine learning techniques. SN Appl Sci. 1(12):1–12.
   Web of Science ®Google Scholar
• Maniruzzaman M, Rahman M, Al-MehediHasan M, Suri HS, Abedin M, El-Baz A, Suri JS. 2018. Accurate diabetes risk stratification using machine learning: role of missing value and outliers. J Med Syst. 42(5):1–17.
   Web of Science ®Google Scholar
• Marcano-Cedeño A, Quintanilla-Domínguez J, Cortina-Januchs MG, Andina D. 2010. Feature selection using sequential forward selection and classification applying artificial metaplasticity neural network. In IECON 2010-36th Annual Conference on IEEE Industrial Electronics Society; p. 2845–2850. IEEE.
   Google Scholar
• McGill W. 1954. Multivariate information transmission. Trans IRE Prof Group Inf Theory. 4(4):93–111.
   Google Scholar
• McHugh ML. 2012. Interrater reliability: the kappa statistic. Biochem Med. 22(3):276–282.
   PubMed Web of Science ®Google Scholar
• McNemar Q. 1947. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 12(2):153–157.
   PubMed Web of Science ®Google Scholar
• Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan W-K, Yilmaz Y, Czernichow S, Zheng M-H, Wong VW-S, et al. 2020. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 5(4):362–373.
   PubMed Web of Science ®Google Scholar
• Okanoue T, Shima T, Mitsumoto Y, Umemura A, Yamaguchi K, Itoh Y, Yoneda M, Nakajima A, Mizukoshi E, Kaneko S, et al. 2021. Artificial intelligence/neural network system for the screening of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatol Res. 51(5):554–569.
   PubMed Web of Science ®Google Scholar
• Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. 2020. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 72(5):1605–1616.
   PubMed Web of Science ®Google Scholar
• Park CH, Park H. 2008. A comparison of generalized linear discriminant analysis algorithms. Pattern Recognit. 41(3):1083–1097.
   Web of Science ®Google Scholar
• Patle A, Chouhan DS. 2013. SVM kernel functions for classification. In 2013 International Conference on Advances in Technology and Engineering (ICATE); pp. 1–9. IEEE.
   Google Scholar
• Priyam A, Abhijeeta GR, Rathee A, Srivastava S. 2013. Comparative analysis of decision tree classification algorithms. Int J Curr Engin Technol. 3(2):334–337.
   Google Scholar
• Radovic M, Ghalwash M, Filipovic N, Obradovic Z. 2017. Minimum redundancy maximum relevance feature selection approach for temporal gene expression data. BMC Bioinf. 18(1):1–14.
   PubMedGoogle Scholar
• Ray A, Chaudhuri AK. 2021. Smart healthcare disease diagnosis and patient management: innovation, improvement and skill development. Machine Learning with Appl. 3:100011.
   Google Scholar
• Razzak MI, Naz S, Zaib A. 2018. Deep learning for medical image processing: overview, challenges and the future. Classification in BioApps:323–350.
   Google Scholar
• Rückert IM, Heier M, Rathmann W, Baumeister SE, Döring A, Meisinger C. 2011. Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One. 6(8):e22932.
   PubMed Web of Science ®Google Scholar
• Shaik AB, Srinivasan S. 2019. A brief survey on random forest ensembles in classification model. In International Conference on Innovative Computing and Communications; p. 253–260. Singapore: Springer.
   Google Scholar
• Styczynski G, Milewska A, Marczewska M, Sobieraj P, Sobczynska M, Dabrowski M, Kuch-Wocial A, Szmigielski C. 2016. Echocardiographic correlates of abnormal liver tests in patients with exacerbation of chronic heart failure. J Am Soc Echocardiogr. 29(2):132–139.
   PubMed Web of Science ®Google Scholar
• Suresha PB, Wang Y, Xiao C, Glass L, Yuan Y, Clifford GD. 2021. A deep learning approach for classifying nonalcoholic steatohepatitis patients from nonalcoholic fatty liver disease patients using electronic medical records. In Explainable AI in healthcare and medicine. Cham: Springer; p. 107–113.
   Google Scholar
• Tahernezhad-Javazm F, Azimirad V, Shoaran M. 2018. A review and experimental study on the application of classifiers and evolutionary algorithms in EEG-based brain–machine interface systems. J Neural Eng. 15(2):021007.
   PubMed Web of Science ®Google Scholar
• Taunk K, De S, Verma S, Swetapadma A. 2019. A brief review of nearest neighbor algorithm for learning and classification. In 2019 International Conference on Intelligent Computing and Control Systems (ICCS); pp. 1255–1260. IEEE.
   Google Scholar
• Tharwat A. 2021. Classification assessment methods. ACI. 17(1):168–192.
   Google Scholar
• Toledo FG, Sniderman AD, Kelley DE. 2006. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care. 29(8):1845–1850.
   PubMed Web of Science ®Google Scholar
• Vergara JR, Estévez PA. 2014. A review of feature selection methods based on mutual information. Neural Comput & Appl. 24(1):175–186.
   Web of Science ®Google Scholar
• Wu CC, Yeh WC, Hsu WD, Islam MM, Nguyen PAA, Poly TN, Wang YC, Yang HC, Li YCJ. 2019. Prediction of fatty liver disease using machine learning algorithms. Comput Methods Programs Biomed. 170:23–29.
   PubMed Web of Science ®Google Scholar
• Xu H, Caramanis C, Mannor S. 2012. Sparse algorithms are not stable: a no-free-lunch theorem. IEEE Trans Pattern Anal Mach Intell. 34(1):187–193.
   PubMed Web of Science ®Google Scholar
• Ying C, Qi-Guang M, Jia-Chen L, Lin G. 2013. Advance and prospects of AdaBoost algorithm. Acta Autom Sin. 39(6):745–758.
   Google Scholar
• Yoneda M, Honda Y, Nogami A, Imajo K, Nakajima A. 2020. Advances in ultrasound elastography for nonalcoholic fatty liver disease. J Med Ultrason (2001). 47(4):521–533.
   PubMed Web of Science ®Google Scholar
• Zheng W, Chilazi M, Park J, Sathiyakumar V, Donato LJ, Meeusen JW, Lazo M, Guallar E, Kulkarni KR, Jaffe AS, et al. 2022. Assessing the accuracy of estimated lipoprotein (a) cholesterol and lipoprotein (a)‐free low‐density lipoprotein cholesterol. J Am Heart Assoc. 11(2):e023136.
   PubMed Web of Science ®Google Scholar